Delivery Order SPE2DR25D7066-SPE2DR26F7ZDN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,059.60 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,130.53 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical and medical device supply portfolio. The contract specifies performance at the vendor's Conshohocken, Pennsylvania location, which serves as...
- The Defense Logistics Agency has awarded a delivery order valued at $8,707.71 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This is a competitively awarded, firm fixed price delivery order with an ultimate completion date of September 22, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,598.25 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for continuous glucose monitoring supplies to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $10,655.70 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $14,645.13 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The sensors constitute specialized medical devices for continuous glucose monitoring, supporting the federal...
- The Defense Logistics Agency awarded a $2,429.85 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of October 23, 2025. This is a firm fixed price, non-set-aside contract executed on October 22, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,720.12 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of June 9, 2025. This non-compete, firm fixed-price delivery order was issued on June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor supporting federal healthcare...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.04 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZDNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,633.32 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The sensors will be delivered to AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026. The Freestyle Libre 3 Plus continuous glucose monitoring sensors support diabetes care requirements across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's position as a prime vendor reflects its demonstrated capability to supply specialized medical devices and pharmaceuticals competitively to meet military and federal healthcare procurement needs on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 11/14/25 |